
electroCore, Inc. (ECOR)
ECOR Stock Price Chart
Explore electroCore, Inc. interactive price chart. Choose custom timeframes to analyze ECOR price movements and trends.
ECOR Company Profile
Discover essential business fundamentals and corporate details for electroCore, Inc. (ECOR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 Jun 2018
Employees
73.00
Website
https://www.electrocore.comCEO
Daniel S. Goldberger
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
ECOR Financial Timeline
Browse a chronological timeline of electroCore, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.33.
Earnings released on 6 Aug 2025
EPS came in at -$0.35 falling short of the estimated -$0.32 by -9.37%, while revenue for the quarter reached $7.38M , missing expectations by -5.91%.
Earnings released on 7 May 2025
EPS came in at -$0.47 surpassing the estimated -$0.56 by +16.07%, while revenue for the quarter reached $6.72M , missing expectations by -3.03%.
Earnings released on 12 Mar 2025
EPS came in at -$0.40 falling short of the estimated -$0.34 by -17.65%, while revenue for the quarter reached $7.05M , missing expectations by -0.13%.
Earnings released on 13 Nov 2024
EPS came in at -$0.31 falling short of the estimated -$0.29 by -6.90%, while revenue for the quarter reached $6.55M , beating expectations by +0.99%.
Earnings released on 7 Aug 2024
EPS came in at -$0.38 surpassing the estimated -$0.39 by +2.56%, while revenue for the quarter reached $6.14M , beating expectations by +10.41%.
Earnings released on 8 May 2024
EPS came in at -$0.53 falling short of the estimated -$0.50 by -6.00%, while revenue for the quarter reached $5.44M , beating expectations by +14.11%.
Earnings released on 13 Mar 2024
EPS came in at -$0.61 falling short of the estimated -$0.55 by -10.91%, while revenue for the quarter reached $5.19M , beating expectations by +4.45%.
Earnings released on 8 Nov 2023
EPS came in at -$0.68 falling short of the estimated -$0.64 by -6.25%, while revenue for the quarter reached $4.51M , beating expectations by +1.30%.
Earnings released on 9 Aug 2023
EPS came in at -$1.03 falling short of the estimated -$1.00 by -3.00%, while revenue for the quarter reached $3.55M , beating expectations by +3.23%.
Earnings released on 3 May 2023
EPS came in at -$1.24 falling short of the estimated -$1.00 by -24.00%, while revenue for the quarter reached $2.78M , missing expectations by -5.76%.
Earnings released on 8 Mar 2023
EPS came in at -$1.22 falling short of the estimated -$1.11 by -9.91%, while revenue for the quarter reached $2.56M , beating expectations by +8.47%.
Stock split effective on 15 Feb 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 3 Nov 2022
EPS came in at -$1.20 falling short of the estimated -$1.05 by -14.29%, while revenue for the quarter reached $1.98M , missing expectations by -12.61%.
Earnings released on 4 Aug 2022
EPS came in at -$1.20 matching the estimated -$1.20, while revenue for the quarter reached $2.16M , beating expectations by +6.92%.
Earnings released on 5 May 2022
EPS came in at -$1.20 falling short of the estimated -$0.75 by -60.00%, while revenue for the quarter reached $1.90M , beating expectations by +7.06%.
Earnings released on 10 Mar 2022
EPS came in at -$1.05 matching the estimated -$1.05, while revenue for the quarter reached $1.49M , missing expectations by -0.71%.
Earnings released on 4 Nov 2021
EPS came in at -$0.90 surpassing the estimated -$1.20 by +25.00%, while revenue for the quarter reached $1.49M , missing expectations by -4.67%.
Earnings released on 5 Aug 2021
EPS came in at -$1.35 surpassing the estimated -$1.65 by +18.18%, while revenue for the quarter reached $1.27M , missing expectations by -0.04%.
Earnings released on 6 May 2021
EPS came in at -$1.65 surpassing the estimated -$1.80 by +8.33%, while revenue for the quarter reached $1.20M , missing expectations by -2.13%.
Earnings released on 11 Mar 2021
EPS came in at -$2.10 falling short of the estimated -$1.50 by -40.00%, while revenue for the quarter reached $928.20K , beating expectations by +4.29%.
Earnings released on 12 Nov 2020
EPS came in at -$1.50 surpassing the estimated -$1.80 by +16.67%, while revenue for the quarter reached $1.08M , missing expectations by -22.22%.
ECOR Stock Performance
Access detailed ECOR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.